Document is current
Any future updates will be listed below
-
Authors
Cook, Florence
Gilbody, Nicky
Hunt, Jenny
Knight, Zoe
Sheldrick, Heulwen
Houghton, Lisa
Ewers, Caroline
Caygill, Michael
Speight, Holly
Nazareth, Irwin
Govender, Roganie
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (300427)
- License Information
-
More Information
Article History
Received: 11 June 2024
Accepted: 15 March 2025
First Online: 14 May 2025
Declarations
:
: Ethical approval for SIP SMART2 was granted by the London Bridge Research Ethics Committee and registered with the Clinical Trial Registry () on 4th March 2022 (Clinical Trial Number: ISRCTN12377415). No additional ethical approval for this sub-study was required, as this was not deemed to be research but an evaluation of Associate PI experiences of undertaking the scheme. All Associate PIs (also co-authors) consented to the virtual discussions and agreed for their completed checklists to be included in this analysis. Informed consent to participate was obtained verbally from all the participants in the study.
: Not applicable.
: Holly Speight is the national manager for the NIHR Associate PI scheme.
